2012China Modern DoctorRequires access

The effect of pravastatin combined with fenofibrate in treatment of mixed hyperlipidemia

Ruan Weijie

Open publisher page 0 citations

Abstract

Objective To investigate the clinical effect of pravastatin and fenofibrate in treatment of mixed hyperlipidemia.Methods All of 211 cases of mixed hyperlipidemia patients were randomly divided into combined group,pravastatin group and fenofibrate group,in which low-dose combination group fenofibrate combination therapy with pravastatin,pravastatin group and fenofibrate group were used to separate treatment of pravastatin and fenofibrate.Clinical lipid levels,efficacy and adverse reactions compared in three groups.Results The total effective rate of combined group was significantly higher than pravastatin group and fenofibrate group(P 0.05).Three groups had no significant difference in adverse events(P 0.05).Conclusion Pravastatin combined with fenofibrate in treatment of mixed hyperlipidemia has a good clinical efficacy,fewer adverse reactions.So it is worthy of clinical use.

About this research paper

What this paper is about

Objective To investigate the clinical effect of pravastatin and fenofibrate in treatment of mixed hyperlipidemia.Methods All of 211 cases of mixed hyperlipidemia patients were randomly divided into combined group,pravastatin group and fenofibrate group,in which low-dose combination group fenofibrate combination therapy with pravastatin,pravastatin group and fenofibrate group were used to separate treatment of pravastatin and fenofibrate.Clinical lipid levels,efficacy and adverse reactions compared in three groups.Results The total effective rate of combined group was significantly higher than pravastatin group and fenofibrate group(P 0.05).Three groups had no significant difference in adverse events(P 0.05).Conclusion Pravastatin combined with fenofibrate in treatment of mixed hyperlipidemia has a good clinical efficacy,fewer adverse reactions.So it is worthy of clinical use.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical effect of pravastatin and fenofibrate in treatment of mixed hyperlipidemia.Methods All of 211 cases of mixed hyperlipidemia patients were randomly divided into combined group,pravastatin group and fenofibrate group,in which low-dose combination group fenofibrate combination therapy with pravastatin,pravastatin group and fenofibrate group were used to separate treatment of pravastatin and fenofibrate.Clinical lipid levels,efficacy and adverse reactions compared in three groups.Results The total effective rate of combined group was significantly higher than pravastatin group and fenofibrate group(P 0.05).Three groups had no significant difference in adverse events(P 0.05).Conclusion Pravastatin combined with fenofibrate in treatment of mixed hyperlipidemia has a good clinical efficacy,fewer adverse reactions.So it is worthy of clinical use.

Key concepts: Pravastatin, Fenofibrate, Medicine, Hyperlipidemia, Adverse effect, Internal medicine, Clinical efficacy, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
The effect of pravastatin combined with fenofibrate in treatment of mixed hyperlipidemia — Research Paper | ScholarLens